Hunziker to leave Roche as Hippe named new CFO
This article was originally published in Scrip
Erich Hunziker, Roche's chief financial officer, chief information officer and deputy head of its executive committee, is retiring at the end of March this year to focus on a "number of board memberships", says Roche.
You may also be interested in...
The UK's main reimbursement bodies made a series of decisions this week that were broadly favorable and largely focused on oncology medicines.
While troubled Valeant was divesting iNova to private equity investors, Novartis announced a pair of oncology-focused deals, out-licensing a brain cancer drug to Midatech and partnering with IBM Watson Health to optimize breast cancer treatment.
Astellas and Pfizer have amended the PROSPER trial protocol in a bid to position Xtandi ahead of Zytiga in the early stage prostate cancer market.